Publicly Listed Company Galmed Plans to Allocate 50% of Cash Reserves to Cryptocurrency
According to ChainCatcher, as reported by PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. has announced the implementation of a digital asset management strategy. The company plans to allocate $10 million (approximately 50% of its current cash reserves) to digital asset investments.
The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. The strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yield, and risk hedging strategies.
To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moonbirds Partners with Football.Fun, Allowing NFT Holders to Claim Pro Pack and 2,000 Reputation Points
Trending news
MoreCrypto prices
More








